[Future direction of adjuvant chemotherapy for breast cancer following new risk categories of St. Gallen Consensus].
Osaki
Akihiko
A
Department of Breast Oncology, Saitama Medical University.
Saeki
Toshiaki
T
D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D061067:Antibodies, Monoclonal, Humanized; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000209:etiology; D017024:Chemotherapy, Adjuvant; D032921:Consensus; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D012306:Risk; D018570:Risk Assessment; D000068878:Trastuzumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068878:Trastuzumab